OARS funding Cancer

The purpose of this Funding Opportunity Announcement (FOA) is to encourage new research into integrative cancer biology by fostering collaborations between investigators currently supported through the Integrative Cancer Biology Program (ICBP) and those currently unaffiliated with the ICBP. These collaborative projects should leverage the existing expertise and resources from within the ICBP research community and combine those with new approaches, technologies or methods to address compelling cancer questions. Therefore, the proposed research projects must involve partnerships between investigators currently supported by ICBP and investigators currently unaffiliated with the program. Applications that focus on projects which neither involve integrative cancer biology research, nor expand individual ICBP investigators' research by adding additional expertise, resources, or approaches, or without affiliation to existing ICBP personnel, are not appropriate to this FOA.

The purpose of this funding opportunity announcement (FOA) is to emphasize the importance of coordination and collaboration across agencies, partners, and organizations to: * improve standardized staging for use in cancer surveillance; * support and simplify the evaluation, maintenance, and updating of cancer staging applications; and * support enhancement of attributes that decrease the system's complexity.

The purpose of the program is to identify international cancer control practices that can be applied to our domestic programs. Program activities will focus on 1) the establishment or strengthening of high quality cancer registries through establishment of centers for excellence in U.S. territories and other CDC global focus regions, 2) technical exchanges between CDC and the awardee, 3) consultations from global experts to help inform CDC's priority cancer activities, and 4) collaboration on the development and dissemination of monographs and other publications that promote evidence-based prevention for cervical (and other HPV-related), breast, lung, skin, colorectal and other types of cancer. Together, these activities represent an important opportunity for CDC to strengthen its programs in cancer prevention and control.

The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Applicants are expected to commit a minimum of 80% of their time to conducting research.

The purpose of this Dear Colleague Letter is to advise you about funding opportunities at the National Science Foundation for the research community to propose research projects or workshops that will gather data on the implementation and impacts of recent science policy initiatives including, but not limited to those noted earlier.  Especially encouraged are proposals that will: Develop new, or improve existing, analytical frameworks for evaluating the impacts of federal science policy initiatives; Explore different agencies' approaches to the implementation of particular policies to examine how variations in approach affect the achievement of intended policy outcomes; Collect case-study or quantitative data that facilitate identification of best practices in science and innovation policy implementation.

Within the framework of the For Women in Science partnership between the L'Oréal Foundation and UNESCO, we are launching the 2014 call for nominations for outstanding women scientist form all over the world. Five 100.000$ prizes will be awarded in march 2014 in Paris to five women scientists, one per region, for the contributions of their research, the strength of their commitments and their impact on society. An international Jury of eminent scientists presided in 2013 by the Nobel Prize winner, Ahmed Zewali, makes the final selection.

The New Scholars Program supports projects to help early- to mid-career women scientists balance family responsibilities with demanding academic careers. New Scholars seeks to actively address the attrition rate of talented women scientists caused by work-life balance issues.

Alex's Lemonade Stand Foundation introduces a new funding opportunity for researchers whose projects are in jeopardy due to the decreased funding available from the National Institutes of Health (NIH). ALSF's Bridge Grants are intended to keep scientist's projects on track while they reapply for NIH funding to ensure novel childhood cancer research projects are not compromised. ALSF's Bridge Grant awards will provide $100,000 for 12 months to be used for supplies, personnel or the Principal Investigator's salary.

he Idea Development Award promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.

The PRCRP Idea Award with Special Focus mechanism is intended to support innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are directly relevant to service members, their families, and other military beneficiaries. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The Idea Award with Special Focus is not intended to support a logical progression of an already established research project. The proposed research project should be novel and innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this award mechanism. Inclusion of preliminary data is discouraged. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects to understand the mechanisms of initiation, or progression of cancer. This award is not intended to support ongoing research in the applicant's laboratory; therefore, inclusion of preliminary data other than serendipitous findings or in very small numbers is not consistent with the exploratory nature of this award.

The Lustgarten Foundation (LF) is the nation's largest private funder of pancreatic cancer research. Our mission is to advance scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer. Thanks to the support of Cablevision, 100% of all our donations go directly to research, which has enabled us to commit $65 Million to outstanding research projects to date.

This FOA emphasizes the importance of coordination and collaboration across agencies, partners, and organizations to improve standardized electronic reporting of laboratory data to central cancer registries for use in cancer surveillance. Specifically, this opportunity will; *facilitate development of standards for electronic reporting to central cancer registries from clinical and anatomic laboratories, *identify and document the barriers and solutions to accurately capture data contained in biomarker/molecular tests *Promote expansion of electronic reporting from laboratories to central cancer registries.

The Postdoctoral Fellowship Award supports exceptionally talented recent doctoral or medical graduates in pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. Those individuals should be exceptionally talented scientists who have demonstrated that they are the "best and brightest" of their peers. Applicants for this award must exhibit a strong desire to pursue a career in breast cancer research. Under this award mechanism, the postdoctoral fellow is considered the Principal Investigator (PI) and, as such, should write the project narrative, training plan, and other application components with appropriate guidance from the mentor. While the PI is not required to have previous experience in breast cancer research, the proposed project and training must focus on breast cancer.

The Fellowships team of UICC is pleased to announce the call for proposals for the 2013 Yamagiwa-Yoshida Memorial International Cancer Study Grants. Please note that the application closing date is set to 1st July 2013. Please find below some key information regarding the fellowship:  WHAT 3 months International Fellowship Award value of USD 10,000 AIMS to initiate, set-up or pursue bilateral cancer research projects with collaborating investigators abroad to receive training in advanced experimental research methods and techniques to exploit complementary skills and material WHO  Individuals with: scientific or medical qualifications and a minimum of two years postdoctoral experience actively engaged in cancer research  have recent publications in the international peer-reviewed literature

Advance your career by visiting another institute: American Cancer Society international fellowships for beginning investigators (ACSBI). The ACSBI fellowship emphasizes the transfer of knowledge from the host institute to others at the home institute. It offers the fellow the opportunity to be mentored by experts in the chosen field, receive hands on experience in clinical, behavioural or basic research, intellectual stimulation, research guidance, narrative transfer and many other opportunities to evolve scientifically and academically. The goals include not only developing future leaders in cancer research in low/middle income countries, but also facilitating a global effort in cancer prevention and control. This will be done by developing the necessary intellectual infrastructure in home countries (since ACSBI fellows must return to their home institute), encouraging collaborative interactions to facilitate interdisciplinary basic and applied cancer research, and establishing a network of researchers and translational scientists for rapid dissemination of new knowledge and technology in developing and sharing of best practices.

The MMRF is providing funding to researchers at the post doctorate/medical fellow or junior faculty levels and working under the supervision or guidance of a research sponsor in the multiple myeloma field.

 The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.

The National Aeronautics and Space Administration (NASA) plans to release a NASA Research Announcement (NRA), for Ground-based Studies for the Space Radiation Program Element (SRPE) in the area of space radiobiology of cancer and neuronal risks utilizing beams of high energy ions simulating space radiation at the NASA Space Radiation Laboratory (NSRL) at Brookhaven National Laboratory (BNL) in Upton, New York.

BCAN's Young Investigator Awards seek to fund those researchers who may be working in basic, translational, clinical, epidemiologic, bioengineering or any other scientific or research field, but are also working in a research environment capable of supporting transformational bladder cancer research.